主 办:北 京 中 医 药 大 学
ISSN 1006-2157 CN 11-3574/R

JOURNAL OF BEIJIGN UNIVERSITY OF TRADITIONAL CHINE ›› 2015, Vol. 38 ›› Issue (11): 777-780.doi: 10.3969/j.issn.1006-2157.2015.11.013

• Original Article • Previous Articles     Next Articles

Clinical efficacy of TCM formula of replenishing qi and resolving phlegm and dispelling stasis on patients with stable chronic obstructive pulmonary disease*

WANG Wei1,WU Haibin2,WANG Qi2#,ZHANG Yongsheng2,HAN Feixiang1,LI Jinting1   

  1. 1 Beijing University of Chinese Medicine, Beijing 100029;
    2 Dongfang Hospital, Beijing University of Chinese Medicine
  • Received:2015-06-11 Online:2015-11-30 Published:2015-11-30

Abstract: Objective To evaluate the clinical efficacy of qi-replenishing, phlegm-resolving and stasis-diapelling formula, a Chinese compound medicine, on the patients of stable stage with chronic obstructive pulmonary disease (COPD). Methods Altogether 51 COPD patients with TCM syndrome of deficiency of lung qi, spleen qi, kidney qi and phlegm-stasis obstruction were randomly divided into Chinese medication group (n=26) and control group (n=25) .The patients of the control group were treated with only routine Western medication, while those of the Chinese medication group were treated with the routine Western medication combined with TCM formula for consecutive four months. Results There were significant differences of forced expiratory volume in one second (FEV1) , changes of symptom scores and COPD assessment test (CAT) scores between after treatment and before treatment in Chinese medication group(P<0.05). Compared with control group, all the indexes mentioned above showed statistical differences in Chinese medication group(P<0.05). Conclusion The clinical efficacy and safety of Chinese formula were proved by the means of comparison of FEV1, symptom scores and CAT scores between Chinese medication group and control group.

Key words: chronic obstructive pulmonary disease, TCM formula of replenishing qi and resolving phlegm and dispelling stasis, qi deficiency and blood stasis and phlegm obstruction, deficiency in origin and excess in superficiality

CLC Number: 

  • R256.12